Literature DB >> 15261576

Protein microarray detection strategies: focus on direct detection technologies.

Virginia Espina1, Elisa C Woodhouse, Julia Wulfkuhle, Heather D Asmussen, Emanuel F Petricoin, Lance A Liotta.   

Abstract

Protein microarrays are being utilized for functional proteomic analysis, providing information not obtainable by gene arrays. Microarray technology is applicable for studying protein-protein, protein-ligand, kinase activity and posttranslational modifications of proteins. A precise and sensitive protein microarray, the direct detection or reverse-phase microarray, has been applied to ongoing clinical trials at the National Cancer Institute for studying phosphorylation events in EGF-receptor-mediated cell signaling pathways. The variety of microarray applications allows for multiple, creative microarray designs and detection strategies. Herein, we discuss detection strategies and challenges for protein microarray technology, focusing on direct detection of protein microarrays.

Mesh:

Substances:

Year:  2004        PMID: 15261576     DOI: 10.1016/j.jim.2004.04.013

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  27 in total

1.  Carbon Nanotubes in Biology and Medicine: In vitro and in vivo Detection, Imaging and Drug Delivery.

Authors:  Zhuang Liu; Scott Tabakman; Kevin Welsher; Hongjie Dai
Journal:  Nano Res       Date:  2009-02-01       Impact factor: 8.897

Review 2.  Broad-based proteomic strategies: a practical guide to proteomics and functional screening.

Authors:  David R M Graham; Steven T Elliott; Jennifer E Van Eyk
Journal:  J Physiol       Date:  2004-12-20       Impact factor: 5.182

Review 3.  Multiplexed and microparticle-based analyses: quantitative tools for the large-scale analysis of biological systems.

Authors:  John P Nolan; Francis Mandy
Journal:  Cytometry A       Date:  2006-05       Impact factor: 4.355

Review 4.  Reverse phase protein microarrays advance to use in clinical trials.

Authors:  Claudius Mueller; Lance A Liotta; Virginia Espina
Journal:  Mol Oncol       Date:  2010-10-16       Impact factor: 6.603

5.  Variable slope normalization of reverse phase protein arrays.

Authors:  E Shannon Neeley; Steven M Kornblau; Kevin R Coombes; Keith A Baggerly
Journal:  Bioinformatics       Date:  2009-03-31       Impact factor: 6.937

6.  Extreme sensitive metasensor for targeted biomarkers identification using colloidal nanoparticles-integrated plasmonic unit cells.

Authors:  Arash Ahmadivand; Burak Gerislioglu; Asahi Tomitaka; Pandiaraj Manickam; Ajeet Kaushik; Shekhar Bhansali; Madhavan Nair; Nezih Pala
Journal:  Biomed Opt Express       Date:  2018-01-02       Impact factor: 3.732

Review 7.  Protein array diagnostics for guiding therapy in rheumatoid arthritis.

Authors:  Peter Szodoray; Philip Alex
Journal:  Mol Diagn Ther       Date:  2011-10-01       Impact factor: 4.074

8.  Quantum Dots as Reporters in Multiplexed Immunoassays for Biomarkers of Exposure to Agrochemicals.

Authors:  M Nichkova; D Dosev; A E Davies; S J Gee; I M Kennedy; B D Hammock
Journal:  Anal Lett       Date:  2007-01       Impact factor: 2.329

9.  Quantification of DNA and protein adsorption by optical phase shift.

Authors:  Emre Ozkumur; Ayça Yalçin; Marina Cretich; Carlos A Lopez; David A Bergstein; Bennett B Goldberg; Marcella Chiari; M Selim Unlü
Journal:  Biosens Bioelectron       Date:  2009-06-26       Impact factor: 10.618

10.  Pathway biomarker profiling of localized and metastatic human prostate cancer reveal metastatic and prognostic signatures.

Authors:  Robert L Grubb; Jianghong Deng; Peter A Pinto; James L Mohler; Arul Chinnaiyan; Mark Rubin; W Marston Linehan; Lance A Liotta; Emanuel F Petricoin; Julia D Wulfkuhle
Journal:  J Proteome Res       Date:  2009-06       Impact factor: 4.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.